Form 4: Doximity Director Timothy Cabral Executes Pre-Planned Stock Sale and Option Exercise

Doximity, Inc. Director Timothy S. Cabral reported the exercise of stock options, conversion of Class B to Class A common stock, and subsequent sale of 10,000 shares of Class A common stock for $60 per share, pursuant to a Rule 10b5-1 trading plan.

Summary

• Timothy S. Cabral, a Director of Doximity, Inc. (DOCS), reported transactions on June 25, 2025.
• Cabral exercised stock options to acquire 10,000 shares of Class B Common Stock at an exercise price of $2.21 per share.
• Concurrently, 10,000 shares of Class B Common Stock were converted into 10,000 shares of Class A Common Stock at the holder's option.
• Following the conversion, Cabral sold 10,000 shares of Class A Common Stock at a price of $60 per share.
• The sale was conducted automatically pursuant to a Rule 10b5-1 trading plan adopted by Cabral on February 13, 2025.
• After these transactions, Cabral's direct beneficial ownership of Class A Common Stock is 6,360 shares, and Class B Common Stock is 383,500 shares.
• The stock option exercised was granted on September 2, 2020, and vested in 36 equal monthly installments after that date, subject to continuous service.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-planned Rule 10b5-1 trading plan mitigates any strong negative signal, as it indicates a planned financial action rather than a reaction to new company-specific information.

Negatives

• A director selling shares, even under a pre-planned Rule 10b5-1 plan, can sometimes be perceived by investors as a signal of reduced confidence, although the pre-planned nature mitigates this to some extent.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details a routine insider transaction (stock option exercise and sale) by a director of Doximity, Inc., a digital platform for medical professionals. Such transactions are common for executives and directors for personal financial planning and diversification, often executed under pre-arranged trading plans like Rule 10b5-1.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be interpreted as a minor signal, but its execution under a 10b5-1 plan suggests it's part of routine financial management rather than a reflection of company performance or outlook.

Key Dates

Keywords

Doximity, DOCS, Timothy S. Cabral, Insider Trading, Form 4, Stock Sale, Stock Option Exercise, Rule 10b5-1 Plan, Director, Equity Transaction, Class A Common Stock, Class B Common Stock